BRVE (Braveheart Bio) Pretax Margin %: % (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BRVE Braveheart Bio Inc BRVE
8 GF Score
Price $31.93
View Full Analysis

What is Braveheart Bio Pretax Margin %?

Braveheart Bio BRVE -2.72% 8 Pretax Margin % is % as of Dec. 2025. GuruFocus rates BRVE with a GF Score™ of 8/100.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Braveheart Bio's Pre-Tax Income for the six months ended in Dec. 2025 was $-66.05 Mil. Braveheart Bio's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Braveheart Bio's pretax margin for the quarter that ended in Dec. 2025 was %.

The historical rank and industry rank for Braveheart Bio's Pretax Margin % or its related term are showing as below:


BRVE's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.9
* Ranked among companies with meaningful Pretax Margin % only.

Braveheart Bio  (NAS:BRVE) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Braveheart Bio Pretax Margin % Related Terms

Braveheart Bio Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Braveheart Bio's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Braveheart Bio Pretax Margin % Chart

Braveheart Bio Annual Data
Trend Dec25
Pretax Margin %
0.00

Braveheart Bio Semi-Annual Data
Dec25
Pretax Margin % 0.00

BRVE vs : Pretax Margin % Comparison

For the Biotechnology subindustry, Braveheart Bio's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Braveheart Bio Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Braveheart Bio's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Braveheart Bio's Pretax Margin % falls into.


BRVE
8GF Score
Braveheart Bio Inc BRVE
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Braveheart Bio Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Braveheart Bio's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-66.052/0
= %

Braveheart Bio's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-66.052/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Braveheart Bio (BRVE) has a Pretax Margin % of % as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Braveheart Bio and its competitors.
Is Braveheart Bio's Pretax Margin % too high?
Braveheart Bio's current Pretax Margin % is %. Overall, Braveheart Bio has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Braveheart Bio's Pretax Margin % compare to ?
Braveheart Bio's Pretax Margin % of % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Braveheart Bio and its competitors. Braveheart Bio's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Braveheart Bio stock overvalued right now?
Braveheart Bio (BRVE) has a current Pretax Margin % of %. The current Pretax Margin % is %. Braveheart Bio's overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Braveheart Bio (BRVE), the current Pretax Margin % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Braveheart Bio Business Description

Comparable Companies
Address One Letterman Drive, Suite A4-300, Building A, San Francisco, CA, USA, 94129
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).
8GF Score

Get the complete analysis for BRVE

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.93
Price